Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic FactorsEleonora Boscaro, Marco Cerrano, Valentina Giai et al.|Cancers|2023Cited by 35
Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of LiteratureGiulia Arrigo, Chiara Frairia, Stefano D’Ardìa et al.|Acta Haematologica|2022Cited by 5
Arsenic trioxide neurotoxicity in acute promyelocytic leukemia patients: a single center experienceGiulia Arrigo, Chiara Frairia, Matilde Scaldaferri et al.|Leukemia & lymphoma/Leukemia and lymphoma|2024Cited by 2
PB2057: THE COMBINATION OF ANTI-COMPLEMENT THERAPY AND CYCLOSPORINE +/- ELTROMBOPAG IN PNH IS EFFECTIVE AND SAFE: A REAL-LIFE OBSERVATIONAL STUDY.Federica Catania, Valentina Giai, Chiara Frairia et al.|HemaSphere|2023Cited by 0